The immunopathogenesis of human immunodeficiency virus infection.
about
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tractContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsHuman herpesvirus 6Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin BThe human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycleModelling the course of an HIV infection: insights from ecology and evolutionTwin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitroCompounds that target novel cellular components involved in HIV-1 transcriptionModeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimesModeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsHIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapyThe Viral Model for AIDS: Paradigmatic Dominance, Politics, or Best Approximation of Reality?Preclinical evaluation of a dual-acting microbicidal prodrug WHI-07 in combination with vanadocene dithiocarbamate in the female reproductive tract of rabbit, pig, and cat.Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.Current concepts in human immunodeficiency virus infection and AIDSHIV and the returning expatriate.Associations of clinical parameters with health-related quality of life in hospitalized persons with HIV disease.Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiologyAnalysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsyT cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infectionActivation of human T-cell leukemia virus type 1 tax gene expression in chronically infected T cells.Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic ControllersQuantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infectionReference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.The clinical utility of viral load monitoring in HIV infection: strengths and limitationsLevels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts.Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.Distinct chemokine triggers and in vivo migratory paths of fluorescein dye-labeled T Lymphocytes in acutely simian immunodeficiency virus SIVmac251-infected and uninfected macaques.Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins oImmune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.Differentially co-expressed interacting protein pairs discriminate samples under distinct stages of HIV type 1 infection.Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load
P2860
Q22242965-EE837A61-2A69-4BD3-A602-AFF5F29F52DCQ24550678-1C661081-9442-4993-9C0F-49D89765AE97Q24651506-68A5B117-F649-435D-8DC9-DCC9C8D015D1Q24683663-A49A12A8-9901-4669-93B6-00950EE8ED50Q24685157-10287C0F-290F-41EA-953F-F91EFC323D7CQ24685965-B8189F01-BCF1-4004-B76B-D27795C01944Q26853307-A050FEEB-B909-40ED-9653-529320993059Q27480750-6E2A3E48-E2E4-445F-BFAD-AD52F65F4277Q28378815-1DF34E04-31B5-462C-82B1-C60A3411B617Q28484046-090469E2-2726-4230-A2BE-2CE3ED3700ADQ28551803-9C4DAF18-6147-4753-897B-D4D94C2661E5Q29616404-F6657912-E902-4832-A7D3-E340D8363D40Q30393620-609079A0-D554-40E4-8F57-A3334A90E5B1Q33311725-5F4665EF-CC55-434A-B5A5-54CEE3E05015Q33354076-C3506F51-1D90-4841-AC59-654261F574D8Q33604959-4AC61F11-944F-492F-AA88-740F9505CCFBQ33606809-AEFC92A7-AE45-4D97-80B6-A1C4B4A89A35Q33669671-89E9AA77-2673-4A7F-93D3-7E628550E946Q33704087-98494C90-CFEC-4CF8-8E44-06C98F01A890Q33707384-58F0B45F-E53C-40CE-AA38-0AA71A325675Q33742029-63CD95EF-4F1C-461E-8CDF-E9B2EA575A14Q33781851-BA1CEABC-3DFA-4373-83BE-786DF519934BQ33782045-3F6369E6-5966-44AB-B5B1-BAF736F12D4BQ33782387-AD900A69-E4B0-4F4B-83DC-B7B39CFD7061Q33785137-83E2E842-02EC-4C55-A1DE-76F8561EE382Q33785951-3E2256EF-9B27-4DFB-9B81-04F6EF4523CFQ33828507-9639A9A6-EC3E-4475-8ADE-C6B4952B47FDQ33847798-8D186F45-C62F-4A1B-A5DF-7BBC95CF1285Q33935910-2044B649-8391-445B-8856-0345A4C2EDFEQ33936351-E778B1C6-76AB-4C01-A811-AC89DDD0F23BQ33943382-31A20134-FF5A-4AFE-80B5-E27E1497F9C8Q34076185-FE0B351F-8466-4AE5-9F45-4AD37CE53BA9Q34092864-95E68669-F22F-4276-B21C-DFDCB3536F75Q34193108-84BDC528-1091-4E88-A441-071E1FC0A673Q34209063-1C292897-146D-435F-908A-CA9F59BF59A2Q34292622-4955CDE8-F16E-43EA-8E8B-29359C33F5CDQ34333397-FF1EA3CB-3576-4BF9-B9C1-CC7C3E2B240CQ34341001-8017C6EE-20D1-47D9-AB60-D60757BAE59AQ34345002-33F8B854-58B3-4BD5-A447-33CC644026BCQ34348055-50680C6E-DD23-4A4C-B499-DAE293C52A95
P2860
The immunopathogenesis of human immunodeficiency virus infection.
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The immunopathogenesis of human immunodeficiency virus infection.
@ast
The immunopathogenesis of human immunodeficiency virus infection.
@en
The immunopathogenesis of human immunodeficiency virus infection.
@nl
type
label
The immunopathogenesis of human immunodeficiency virus infection.
@ast
The immunopathogenesis of human immunodeficiency virus infection.
@en
The immunopathogenesis of human immunodeficiency virus infection.
@nl
prefLabel
The immunopathogenesis of human immunodeficiency virus infection.
@ast
The immunopathogenesis of human immunodeficiency virus infection.
@en
The immunopathogenesis of human immunodeficiency virus infection.
@nl
P1476
The immunopathogenesis of human immunodeficiency virus infection.
@en
P2093
C Graziosi
G Pantaleo
P304
P356
10.1056/NEJM199302043280508
P407
P577
1993-02-01T00:00:00Z